Testing Financial News

Subscribe to enjoy similar stories.Explorers have dreamed of harvesting deep-sea metals since the 1870s, when the British scientific ship HMS Challenger pulled up mineral-laden rocks on its round-the-world voyage.The first commercial effort to exploit these riches failed a century later. In 1970, a U.S.

Subscribe to enjoy similar stories.In a volatile market like present times — marked by global uncertainties, intermittent buying at dips, foreign outflows, and fluctuating risk appetite — valuations are under constant scrutiny.In this backdrop, the PEG ratio is emerging as a much-needed reality check by tying price more closely to growth.The PEG or (Price/Earnings-to-Growth) ratio compares a stock’s P/E multiple with its expected earnings growth, typically over the next couple of years, to assess whether its valuation is justified.A PEG around 1 is seen as fair value, below 1 may indicate undervaluation, and above 1 could signal overpricing — helping investors separate genuine growth stories from stocks that look expensive without enough momentum, explained market participants.When money chases growth stocks, PEG helps assess whether high P/E multiples are justified by earnings growth, since a rise in P/E only makes sense if earnings grow at a similar pace, explained Rohit Srivastava, founder and market strategist at equity-research firm indiacharts.com.Aniruddha Sarkar, co-founder & CIO, Equinova Investment Managers, pointed out that companies with low P/E but high PEG ratios may look cheap at first glance but lack the growth to justify it.In contrast, stocks with high P/E but low PEG ratios usually reflect strong earnings momentum, where the premium is backed by solid growth prospectsm he added.For instance, La Opala trades at a trailing P/E of 18.6 with a steep PEG of 27.8, suggesting limited growth support, while 360 One WAM, despite a higher P/E of 34.8, has a more reasonable PEG of 1.5.

Subscribe to enjoy similar stories.Quick commerce is evolving beyond a distribution channel into a testing ground for product innovation, enabling brands—from new-age to legacy players, across categories from milk to makeup—to launch, refine and scale offerings.The appeal lies in the cost advantage over traditional rollouts, particularly for smaller brands that can test in small batches, track repeat purchases and tweak products in real time.“Rather than spending ₹10 crore on a big-bang launch, brands can test with ₹20-30 lakh and see what works,” said Sashi Kumar of organic dairy enterprise Akshayakalpa Organic.The Bengaluru-based firm launched its high-protein milk exclusively on Swiggy to validate demand. “The expectation was not volumes, but whether consumers come back and buy again,” Kumar said, adding that the channel removes hurdles like listing fees and in-store promotions, while offering sharper targeting and faster feedback.Strong repeat rates helped Akshayakalpa, whose quick-commerce business is growing about 40% year-on-year, to scale the product offline.Beyond staples, the model is also gaining traction in seasonal and impulse-driven categories.

Subscribe to enjoy similar stories.The people who gather in this small room on the eighth floor of the New York Stock Exchange look like a group of middle-aged caffeine addicts.They sit around what resembles a school science lab sniffing coffee beans and slurping coffee so aggressively that there’s loud music playing to drown them out.But these aren’t junkies with bad manners. They’re part of an elite team of graders who help keep the commodities market running. Their ratings help set U.S.

Subscribe to enjoy similar stories.Last week, Anthropic announced that its latest artificial intelligence (AI) model, Claude Mythos, was too dangerous to release. In testing, the company discovered that the model could unearth thousands of hitherto unknown security vulnerabilities in many of the software applications, operating systems and web browsers that the world depends on.

Subscribe to enjoy similar stories.After building a ₹1,000-crore FMCG business on ghee over four decades, GRB Dairy Foods Pvt. Ltd.

Subscribe to enjoy similar stories.A combustible mix of policymaker FOMO, industry self-interest and parental anxiety about the future of work is fuelling Asia’s push to introduce AI into classrooms at ever younger ages. The result risks turning a generation of developing minds into guinea pigs, while gains flow not to students, but to tech companies.You don’t have to be a Luddite to see the problem: AI’s inherent promise is convenience, while learning requires effort. Those aims are fundamentally at odds.

, a 22-employee company with operations in Shanghai and San Diego, had been working on its own therapies. By poring over the patents from Western companies, the biotech found clues to improve its drug candidates.Within months, GluBio had made tweaks that produced more powerful and targeted therapies.

Under mounting global scrutiny, India has cracked down on paediatric cough syrups, with the health ministry proposing to bar prescription of cough and cold medications for babies below two years of age and also discouraging them for children below five, according to two government officials and documents reviewed by Mint.The move, part of the draft National Formulary of India (NFI) 2026 published by the Indian Pharmacopoeia Commission (IPC), under the health ministry, marks a sharp regulatory tightening after contamination-linked deaths, with implications for prescribing practices and a fast-growing market.The NFI draft has standardized information on drug dosages, indications, contra-indications and side-effects for doctors and pharmacists.The development assumes importance for India’s cough syrup market, that was valued at $262.5 million in 2024 and is projected to grow to $743 million by 2035.This regulatory tightening follows alarm over discovery of toxic industrial solvents, including diethylene glycol (DEG) and ethylene glycol (EG), in liquid oral formulations, which could lead to acute kidney failure and even death, thereby denting India’s image as the ‘pharmacy of the world’.The draft highlights the life-threatening risks of DEG and EG contamination and follows a Directorate General of Health Services (DGHS) October advisory to states to address the public health crisis following deaths in Rajasthan and Madhya Pradesh.“As we look back at the historical precedents, the tragic deaths linked to cough syrups were primarily caused by poisonous ingredients like diethylene glycol (DEG), which induces severe poisoning symptoms.

full Q4 earnings report by Jas Bardia.Inside Anthropic’s Project Glasswing: Can AI outsmart hackers before they strike? That’s the big idea that powers Anthropic’s Project Glasswing—a coalition using advanced AI to detect hidden software flaws even experts miss.With cyberattacks rising and a shortage of skilled professionals, this could be a game-changer. The AI can not only spot “zero-day” vulnerabilities but also suggest fixes, potentially transforming how cybersecurity works.

NEW DELHI: India plans to restrict the testing of vaccines and specialized biological products exclusively to government-controlled laboratories to maintain quality standards, according to two government officials and documents reviewed by Mint. This new approach will affect private laboratory operators and the pharmaceutical manufacturers that rely on them for faster testing turnaround times.Under the existing rules, private labs are allowed to test specified drugs including vaccines and biologicals.

The US-Iran ceasefire, framed as a two-week conditional truce, offers relief but is less of a resolution than a pause in a fast-escalating crisis. It follows nearly 40 days of sustained US-Israeli military pressure on Iran, itself an extension of the unresolved tensions that persisted after the 2025 Iran-Israel confrontation. In that sense, this ceasefire is simply a momentary recalibration in a longer strategic contest.At its core, the arrangement reflects a transactional bargain.

New York Magazine. Her piece moved from a day-care worker mocked for words like “juxtaposition” and “circumstantial” to a Moroccan writer accused within minutes of submitting work, to a business professor raised across Asia who said the English textbooks he learned from had given him precisely the kind of vocabulary people now associate with ChatGPT. The writers with autism she spoke to said this was not new.

Stock market recap: India’s benchmark indices Sensex and Nifty 50 ended with strong gains on Monday, 6 April, rising more than 1% each amid easing crude oil prices and further recovery in the Indian rupee.Extending gains to the third consecutive session, the Sensex ended 787 points, or 1.07%, higher at 74,106.85, while the Nifty 50 settled at 22,968.25, rising 255 points, or 1.12%. The BSE 150 Midcap index gained 1.30%, while the BSE 250 Smallcap index rose by 1.10%.Investor wealth rose by more than ₹5 trillion in a single session as the overall market capitalization of BSE-listed firms rose to over ₹427 trillion.Buy: Titan Co. Ltd(current price: ₹4,246)Buy: Schneider Electric Infrastructure Ltd (current price: ₹926)Nifty 50 performance on 6 AprilThe Nifty 50 opened on a positive note and sustained buying momentum throughout the session.

The US-Israel attack on Iran has profound implications for the long-term stability of the West Asian region, global geopolitics, energy security and global economics. The expanding nature of the conflict is spawning a long list of collateral damages, amplifying vulnerabilities wherever they exist.

OTT platforms engage a smaller but paying audience, offering higher completion rates and longer shelf life.According to the Ficci EY Media and Entertainment Report 2026, TVoD revenues in India are projected to rise from ₹500 crore in 2025 to ₹740 crore by 2028. Yet monetization remains skewed towards micro-transactions and subscription models, rather than pay-per-view-led revenue.YouTube is India’s leading ad-supported video platform by reach and watch time, reaching four out of five internet users aged 18 and above.

Mint reported on 25 March that about ₹18,000 crore of planned fundraising was at risk.“There is a direct impact on the supply chain, but there is a second-order impact too, which is what we try to understand and work with our clients,” said Singh. “Based on the impact on currency, commodity and their own input pricing changes, we also do a real-time risk assessment as much as we can and make sure that the client is also aware of that.”Singh said Standard Chartered is involved in a large number of loan syndications in the country.

India’s capital markets have grown at a remarkable speed. Retail participation has surged, institutional capital has deepened and technology has transformed intermediation. Regulation has expanded alongside.

Mint, the new norms prescribe test methods to measure the presence of dimethylformamide (DMF) and polycyclic aromatic hydrocarbons (PAHs), respectively. Both substances are commonly used in footwear manufacturing and can pose health risks with prolonged exposure.DMF is widely used as a solvent in the production of polyurethane-based synthetic leather and components.

Mint India Investment Summit held in Mumbai last week.Backed by Zerodha founders' investment vehicles Rainmatter and Gruhas, SuperYou is a modern Indian health and nutrition brand. Co-founded by actor Ranveer Singh and entrepreneur Biyani in late 2024, the brand is focused on fermented yeast-based, high-protein snacks and supplements.“The opportunity to start and find PMF (product-market-fit) with consumers is better than ever before.

Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.